Benjamin R Morgan1, Hassan N Ibrahim. 1. Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN 55414, USA.
Abstract
PURPOSE OF REVIEW: Living kidney donors face a unique decision of self-sacrifice that is not without potential risk. The purpose of this review is to highlight existing research regarding the perioperative morbidity, mortality and long-term outcomes of living kidney donors. RECENT FINDINGS: Recent studies of long-term donor survival have affirmed that the life expectancy for living kidney donors is excellent and their risk of end-stage renal disease (ESRD) is not increased. Long-term health outcomes for living donors representing minority groups, however, may not be as favorable. Recent studies conclude that African-American and Hispanic donors, similarly to nondonors of the same race, are at higher risk of developing chronic kidney disease (CKD), hypertension, and diabetes mellitus. Outcomes in medically complex donors have also generated considerable attention, and the evidence on outcomes among otherwise healthy obese and older donors appears to be reassuring. SUMMARY: Living kidney donation is a superior transplantation option for many individuals with ESRD. The survival and health consequences of living donation have proven to be excellent. These favorable outcomes stem from careful screening measures, and further research endeavors are needed to ensure long-term living donor safety in high-risk donors.
PURPOSE OF REVIEW: Living kidney donors face a unique decision of self-sacrifice that is not without potential risk. The purpose of this review is to highlight existing research regarding the perioperative morbidity, mortality and long-term outcomes of living kidney donors. RECENT FINDINGS: Recent studies of long-term donor survival have affirmed that the life expectancy for living kidney donors is excellent and their risk of end-stage renal disease (ESRD) is not increased. Long-term health outcomes for living donors representing minority groups, however, may not be as favorable. Recent studies conclude that African-American and Hispanic donors, similarly to nondonors of the same race, are at higher risk of developing chronic kidney disease (CKD), hypertension, and diabetes mellitus. Outcomes in medically complex donors have also generated considerable attention, and the evidence on outcomes among otherwise healthy obese and older donors appears to be reassuring. SUMMARY: Living kidney donation is a superior transplantation option for many individuals with ESRD. The survival and health consequences of living donation have proven to be excellent. These favorable outcomes stem from careful screening measures, and further research endeavors are needed to ensure long-term living donor safety in high-risk donors.
Authors: James R Rodrigue; Aaron Fleishman; Tanya Vishnevsky; James Whiting; John P Vella; Krista Garrison; Deonna Moore; Liise Kayler; Prabhakar Baliga; Kenneth D Chavin; Seth Karp; Didier A Mandelbrot Journal: Transpl Int Date: 2014-03-29 Impact factor: 3.782
Authors: James R Rodrigue; Matthew J Paek; Ogo Egbuna; Amy D Waterman; Jesse D Schold; Martha Pavlakis; Didier A Mandelbrot Journal: Prog Transplant Date: 2014-12 Impact factor: 1.187
Authors: Danielle Berglund; David MacDonald; Scott Jackson; Richard Spong; Naim Issa; Aleksandra Kukla; Scott Reule; Marc Weber; Arthur J Matas; Hassan N Ibrahim Journal: Clin Transplant Date: 2014-02-19 Impact factor: 2.863
Authors: Glen M Blake; Christopher Sibley-Allen; Rachel Hilton; Lisa Burnapp; Masood R Moghul; David Goldsmith Journal: Int Urol Nephrol Date: 2013-03-06 Impact factor: 2.370
Authors: Clintoria R Williams; Brandi M Wynne; Makeeva Walker; Robert S Hoover; Jennifer L Gooch Journal: J Cell Mol Med Date: 2014-10-07 Impact factor: 5.310
Authors: Jeannette D Widmer; Andrea Schlegel; Philipp Kron; Marc Schiesser; Jens G Brockmann; Markus K Muller Journal: BMC Urol Date: 2018-05-10 Impact factor: 2.264